Current status of controlled onco-therapies based on metal organic frameworks-Reference-Cited by-同舟云学术

Current status of controlled onco-therapies based on metal organic frameworks

Published:2024 Issue:18 Volume:14 Page:12817-12828
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Yang Yixuan¹,Dai Xiaofeng¹^ORCID

Affiliation:

1. National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Provincial Center for Regenerative Medicine and Surgical Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China

Abstract

Most MOFs for controllable cancer treatment act as drug delivery vehicle and/or anti-cancer agent. Molecules with anti-cancer roles such as chemotherapies, gases, peptides or nucleic acids can be loaded into MOFs that decompose in cancer cells or in the TME to release its cargoes.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D4RA00375F

Reference115 articles.

1. Cancer statistics, 2023

2. Metal–organic frameworks: Structures and functional applications

3. Large-Pore Apertures in a Series of Metal-Organic Frameworks

4. Dinuclear Gold(I) Pyrrolidinedithiocarbamato Complex: Cytotoxic and Antimigratory Activities on Cancer Cells and the Use of Metal-Organic Framework

5. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Slowing Down the “Magic Bullet”: Encapsulation of Imatinib in Fe-MOF for Cardiotoxicity Reduction and Improvement in Anticancer Activity;Molecules;2024-08-12